OYSTER PT PHARMA INC (OYST)
Institutional ownership reported to the SEC as of Q2 2026, across 27 quarters.
1
Reporting holders
$11
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| HUNTINGTON NATIONAL BANK | $11 | 1 | 0.00% | 19q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1 | $11 | 1 | 0 | 0 | 0 | 0.0% |
| Q1 2026 | 1 | $11 | 1 | 0 | 0 | 0 | 0.0% |
| Q4 2025 | 1 | $11 | 1 | 0 | 0 | 0 | 0.0% |
| Q3 2025 | 1 | $11 | 1 | 0 | 0 | 0 | 0.0% |
| Q2 2025 | 1 | $11 | 1 | 0 | 0 | 0 | 0.0% |
| Q1 2025 | 1 | $11 | 1 | 0 | 0 | 0 | 0.0% |
| Q4 2024 | 1 | $11 | 1 | 0 | 0 | 0 | 0.0% |
| Q3 2024 | 1 | $11 | 1 | 0 | 0 | 0 | 0.0% |
| Q2 2024 | 1 | $11 | 1 | 0 | 0 | 0 | 0.0% |
| Q1 2024 | 1 | $11 | 1 | 0 | 0 | 0 | 0.0% |
| Q4 2023 | 1 | $11 | 1 | 0 | 0 | 0 | 0.0% |
| Q3 2023 | 1 | $11 | 1 | 0 | 0 | 0 | 0.0% |
| Q2 2023 | 1 | $11 | 1 | 0 | 0 | 0 | 0.0% |
| Q1 2023 | 1 | $11 | 1 | 0 | 0 | 1 | 0.0% |
| Q4 2022 | 47 | $181.8M | 16,122,536 | 18 | 10 | 7 | 0.9% |
| Q3 2022 | 58 | $112.8M | 20,035,081 | 10 | 10 | 15 | 0.1% |
| Q2 2022 | 55 | $87.6M | 20,220,653 | 9 | 13 | 15 | 0.0% |
| Q1 2022 | 72 | $246.3M | 21,150,813 | 12 | 16 | 20 | 0.0% |
| Q4 2021 | 80 | $382.6M | 20,785,869 | 23 | 20 | 16 | 0.9% |
| Q3 2021 | 68 | $211.0M | 17,781,168 | 18 | 16 | 16 | 0.1% |
| Q2 2021 | 56 | $318.3M | 18,516,250 | 5 | 20 | 14 | 0.0% |
| Q1 2021 | 61 | $335.9M | 18,373,785 | 9 | 15 | 17 | 0.0% |
| Q4 2020 | 60 | $331.1M | 17,594,616 | 5 | 27 | 12 | 0.0% |
| Q3 2020 | 66 | $383.0M | 18,142,415 | 6 | 19 | 20 | 0.0% |
| Q2 2020 | 72 | $520.0M | 18,006,267 | 31 | 24 | 8 | 0.0% |
| Q1 2020 | 43 | $464.7M | 13,315,212 | 9 | 11 | 12 | 0.0% |
| Q4 2019 | 41 | $332.4M | 13,638,925 | 38 | 0 | 0 | 0.0% |